๐Ÿ—‚๏ธ

Archived grant โ€” no longer open

This grant has closed and is kept as a historical reference. Browse current grants for active opportunities.

grant

NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer Care

Organization DANA-FARBER CANCER INSTLocation BOSTON, UNITED STATESPosted 5 Mar 2019Deadline 28 Feb 2026 โš ๏ธ
NIHUS FederalResearch GrantFY2025AmericanBiometricsBiometryBiostatisticsBreastBreast CancerCancer BurdenCancer PatientCancer TreatmentCancersClinical TrialsColon or RectumColorectalCommunitiesDF/HCCDana-Farber Cancer InstituteFutureGeneral HospitalsGrantHead and NeckHead and neck structureHospitalsInvestigatorsLeadLeadershipLungLung Respiratory SystemMalignant Breast NeoplasmMalignant MelanomaMalignant Neoplasm TherapyMalignant Neoplasm TreatmentMalignant NeoplasmsMalignant Ovarian NeoplasmMalignant Ovarian TumorMalignant Soft Tissue NeoplasmMalignant TumorMalignant Tumor of the LungMalignant Tumor of the OvaryMalignant neoplasm of lungMalignant neoplasm of ovaryMalignant neoplasm of prostateMalignant prostatic tumorMassachusettsMedicalMelanomaMissionModalityMultiple MyelomaNCI OrganizationNational Cancer BurdenNational Cancer InstituteNational Clinical Trials NetworkOperative ProceduresOperative Surgical ProceduresOvary CancerPatient outcomePatient-Centered OutcomesPatient-Focused OutcomesPatientsPb elementPilot ProjectsPlasma-Cell MyelomaProstateProstate CAProstate CancerProstate GlandProstate malignancyProstatic GlandPulmonary CancerPulmonary malignant NeoplasmRadiation therapyRadiotherapeuticsRadiotherapyResearch PersonnelResearchersSarcomaScientific Advances and AccomplishmentsSiteSocietiesSupportive TherapySupportive careSurgicalSurgical InterventionsSurgical ProcedureSymptomsTeaching HospitalsTranslational ResearchTranslational ScienceWomananti-cancer therapycancer carecancer therapycancer typecancer-directed therapycolorectumdesigndesigningexperimentexperimental researchexperimental studyexperimentsfightingheavy metal Pbheavy metal leadimprovedimproved outcomeinnovateinnovationinnovativeleukemialung cancermalignancymalignant breast tumormalignant soft tissue tumormyelomamyelomatosisneoplasm/cancerovarian cancerparticipant enrollmentpatient enrollmentpatient oriented outcomespilot studypre-clinicalpreclinicalradiation treatmentscientific accomplishmentsscientific advancesstandard carestandard treatmentsupport networksurgerytranslation researchtranslational investigationtreatment with radiationtumor

Applications closed.

Description preview

Project Summary
This grant supports Network Lead Academic Participating Site (NLAPS) at Dana-Farber/Partners Cancer Care

โ€“ a community of investigators and clinicians committed to reduce the burden of cancer in American society by

contributing scientific leadership and patient accrual to the National Clinical Trials Network (NCTN) activities ofโ€ฆ

๐Ÿ”’

Full details available on the Agency plan

Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link โ€” plus alerts, pipeline tracking, and CSV export.

Start 7-day free trial โ€” $29.99/mo โ†’

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more โ€” with email alerts and pipeline tracking.

$29.99 / month

  • ๐Ÿ””Email alerts for new matching tenders
  • ๐Ÿ—‚๏ธTrack tenders in your pipeline
  • ๐Ÿ’ฐFilter by contract value
  • ๐Ÿ“ฅExport results to CSV
  • ๐Ÿ“ŒSave searches with one click
Start 7-day free trial โ†’
NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer Care โ€” DANA-FARBER CANCER INST | UNITED STATES | Ma | Dev Procure